BRIEF-BioNTech Says Pfizer,Co Request Regulatory Agencies Expand Emergency Use Of Their Covid-19 Vaccine To Adolescents
BRIEF-BioNTech Says Pfizer,Co Request Regulatory Agencies Expand Emergency Use Of Their Covid-19 Vaccine To Adolescents
* PFIZER AND BIONTECH REQUEST REGULATORY AGENCIES EXPAND EMERGENCY USE OF THEIR COVID-19 VACCINE TO ADOLESCENTS
* REQUESTED AMENDMENTS TO U.S. EUA OF THE PFIZER-BIONTECH VACCINE TO EXPAND USE IN ADOLESCENTS 12 TO 15 YEARS OF AGE
* REQUESTS BASED ON DATA FROM PIVOTAL PHASE 3 TRIAL IN ADOLESCENTS 12 TO 15 YEARS OF AGE WITH OR WITHOUT PRIOR EVIDENCE OF SARS-COV-2 INFECTION
* COMPANIES PLAN TO REQUEST SIMILAR RULINGS BY OTHER REGULATORY AUTHORITIES WORLDWIDE IN COMING DAYS
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;)
April 9 (Reuters) - BioNTech SE :
* PFIZER AND BIONTECH REQUEST REGULATORY AGENCIES EXPAND EMERGENCY USE OF THEIR COVID-19 VACCINE TO ADOLESCENTS
* REQUESTED AMENDMENTS TO U.S. EUA OF THE PFIZER-BIONTECH VACCINE TO EXPAND USE IN ADOLESCENTS 12 TO 15 YEARS OF AGE
* REQUESTS BASED ON DATA FROM PIVOTAL PHASE 3 TRIAL IN ADOLESCENTS 12 TO 15 YEARS OF AGE WITH OR WITHOUT PRIOR EVIDENCE OF SARS-COV-2 INFECTION
* COMPANIES PLAN TO REQUEST SIMILAR RULINGS BY OTHER REGULATORY AUTHORITIES WORLDWIDE IN COMING DAYS
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;)
路透4月9日電-BioNTech SE：*輝瑞和BioNtech要求監管機構將其新冠肺炎疫苗的緊急使用範圍擴大至青少年*要求修改輝瑞-BioNTech疫苗的美國EUA，以擴大在12至15歲青少年中的使用*基於有或沒有SARS-COV-2感染先前證據的12至15歲青少年關鍵階段3期試驗的數據提出的請求*公司計劃在未來幾天要求全球其他監管機構做出類似裁決Eikon的源文本：進一步的公司報道：(Reurs.Briefs@thomsonreurs.com；)
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧